Great Britain authorizes the markets the emergence of a second vaccine against the COVID-19, convertiéndose in the first country in it has been given an injection of its most vulnerable and that its developers hope to be able to evacuate to the world ”.
The Department of Health indicates that it has accepted the recommendation of the Regulatory Agency for Medicines and Medical Products to authorize the vaccine to be released by the University of Oxford and the British pharmaceutical AstraZeneca.
Great Britain has demanded 100 million doses of the vaccine and plan to start with its administration in the coming days. Hundreds of thousands of people in the United Kingdom have received a distinct vaccine, developed by the pharmaceutical company Pfizer and its German ally BioNTech.
AstraZeneca’s executive director Pascal Soriot said “he is an important day for millions of people in the United Kingdom who will have access to this new car. It has been demonstrated to be effective, well tolerated and easy to administer, and is managed by AstraZeneca sin lucro ”.
“We will be pleased to welcome our colleagues at AstraZeneca, the University of Oxford, to the British government and the tens of thousands of participants in clinical trials,” he said.
The particular results of the studies in 24,000 people in Great Britain, Brazil and South Africa today mean that the injection is safe and has a 70% increase in risk of getting infected with a coronavirus infection.
The effectiveness has not been as high as the other possible vacancies, but Soriot recently declared in the Sunday Times diary that he confirms that the vacancy demonstrates that it is as effective as the competing companies.
The vaccines against the coronavirus habitually were administered in doses, an initial injection and a reflux administered every three weeks.
But the British governor said that with the AstraZeneca vaccine the priority would be to administer a single dose to the mayor of a possible number of people, who would be forced to offer enormous protection against the virus. Indicated that the first is injected into the population in mayor, and that all receive a second dose one 12 weeks after the initial injection.
“The campaign will start on January 4th and will actually accelerate in the first weeks of next year,” said British Secretary of Health Matt Hancock in a statement to Sky News.
Various countries are expected to depend on the Oxford-AstraZeneca caravan at their low cost, availability and ease of use. Can maintain refrigerators in place of ultra-refrigerators that generally require other vacancies. The company said it would sell each dose for $ 2.50 and plan to make 3,000 million doses before it expires in 2021.
“We have a vacancy for the world,” said one of the study’s readers, Andrew Pollard, of Oxford University.